Quantitation of human papillomavirus DNA in plasma of oropharyngeal carcinoma patients

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 3, 2012, Pages

  Cao, Hongbin ^a   Banh, Alice ^a   Kwok, Shirley ^a   Shi, Xiaoli ^a   Wu, Simon ^a   Krakow, Trevor ^a   Khong, Brian ^a   Bavan, Brindha ^a   Bala, Rajeev ^a   Pinsky, Benjamin A ^a   Colevas, Dimitrios ^a   Pourmand, Nader ^b   Koong, Albert C ^a   Kong, Christina S ^a   Le, Quynh Thu ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of California Santa Cruz   (United States)

Author keywords

Circulating DNA; Human papillomavirus; Oropharyngeal carcinoma; Plasma; Radiotherapy

Indexed keywords

CARCINOMA PATIENTS; CIRCULATING DNA; COPY NUMBER; CULTURE MEDIA; DNA QUANTIFICATION; HEAD-AND-NECK CANCER; HUMAN PAPILLOMAVIRUS; IN-SITU HYBRIDIZATION; OROPHARYNGEAL; PLASMA SAMPLES; PRE-TREATMENT; QUANTITATIVE POLYMERASE CHAIN REACTION; TEMPORAL CHANGE; TUMOR VOLUMES;

CELL CULTURE; DISEASES; DNA; MAMMALS; PLASMAS; POLYMERS; POSITRON EMISSION TOMOGRAPHY; RADIOTHERAPY; TUMORS;

POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENT; CYCLIN DEPENDENT KINASE INHIBITOR 2A; FLUORODEOXYGLUCOSE F 18; PROTEIN E6; PROTEIN E7; VIRUS DNA;

ADULT; AGED; ANIMAL CELL; ARTICLE; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; CULTURE MEDIUM; DNA DETERMINATION; FEMALE; HELA CELL; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; IN SITU HYBRIDIZATION; MALE; MOUSE; NONHUMAN; OROPHARYNX CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR VOLUME; TUMOR XENOGRAFT; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; GENE DOSAGE; GENETIC MARKERS; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MALE; MICE; MICE, SCID; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR BURDEN; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84856369561     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.05.061     Document Type: Article

References (35)

1. M.L. Gillison, W.M. Koch, and R.B. Capone Evidence for a causal association between human papillomavirus and a subset of head and neck cancers J Natl Cancer Inst 92 2000 709 720
2. G. D'Souza, A.R. Kreimer, and R. Viscidi Case-control study of human papillomavirus and oropharyngeal cancer N Engl J Med 356 2007 1944 1956
3. M.L. Gillison, G. D'Souza, and W. Westra Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers J Natl Cancer Inst 100 2008 407 420
4. A.K. Chaturvedi, E.A. Engels, and W.F. Anderson Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States J Clin Oncol 26 2008 612 619
5. P. Attner, J. Du, and A. Nasman The role of human papillomavirus in the increased incidence of base of tongue cancer Int J Cancer 126 2010 2879 2884
6. S.A. Leon, B. Shapiro, and D.M. Sklaroff Free DNA in the serum of cancer patients and the effect of therapy Cancer Res 37 1977 646 650
7. H. Usadel, J. Brabender, and K.D. Danenberg Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer Cancer Res 62 2002 371 375
8. Z.M. Shao, J. Wu, and Z.Z. Shen p53 Mutation in plasma DNA and its prognostic value in breast cancer patients Clin Cancer Res 7 2001 2222 2227
9. P. Anker, J. Lyautey, and C. Lederrey Circulating nucleic acids in plasma or serum Clin Chim Acta 313 2001 143 146
10. Y.M. Lo, L.Y. Chan, and K.W. Lo Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma Cancer Res 59 1999 1188 1191
11. A. Mutirangura, W. Pornthanakasem, and A. Theamboonlers Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma Clin Cancer Res 4 1998 665 669
12. M. Utting, W. Werner, and G. Muller A possible noninvasive method for the detection of bladder cancer in patients: Microsatellite analysis of free DNA in urine and blood Ann NY Acad Sci 945 2001 31 35
13. Y.M. Lo, L.Y. Chan, and A.T. Chan Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma Cancer Res 59 1999 5452 5455
14. T.H. La, E.J. Filion, and B.B. Turnbull Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer Int J Radiat Oncol Biol Phys 74 2009 1335 1341
15. J.C. Lin, K.Y. Chen, and W.Y. Wang Detection of Epstein-Barr virus DNA the peripheral-blood cells of patients with nasopharyngeal carcinoma: Relationship to distant metastasis and survival J Clin Oncol 19 2001 2607 2615
16. J.C. Lin, W.Y. Wang, and K.Y. Chen Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma N Engl J Med 350 2004 2461 2470
17. A.T. Chan, Y.M. Lo, and B. Zee Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma J Natl Cancer Inst 94 2002 1614 1619
18. Q.T. Le, C.D. Jones, and T.K. Yau A comparison study of different PCR assays in measuring circulating plasma Epstein-Barr virus DNA levels in patients with nasopharyngeal carcinoma Clin Cancer Res 11 2005 5700 5707
19. Y.C. Wei, Y.S. Chou, and T.Y. Chu Detection and typing of minimal human papillomavirus DNA in plasma Int J Gynaecol Obstet 96 2007 112 116
20. N. Sathish, P. Abraham, and A. Peedicayil HPV DNA in plasma of patients with cervical carcinoma J Clin Virol 31 2004 204 209
21. P. Kay, B. Allan, and L. Denny Detection of HPV 16 and HPV 18 DNA in the blood of patients with cervical cancer J Med Virol 75 2005 435 439
22. V.W. Liu, P. Tsang, and A. Yip Low incidence of HPV DNA in sera of pretreatment cervical cancer patients Gynecol Oncol 82 2001 269 272
23. H.J. Yang, V.W. Liu, and P.C. Tsang Quantification of human papillomavirus DNA in the plasma of patients with cervical cancer Int J Gynecol Cancer 14 2004 903 910
24. R.B. Capone, S.I. Pai, and W.M. Koch Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma Clin Cancer Res 6 2000 4171 4175
25. C.S. Kong, B. Narasimhan, and H. Cao The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas Int J Radiat Oncol Biol Phys 74 2009 553 561
26. T. Sano, T. Oyama, and K. Kashiwabara Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions Am J Pathol 153 1998 1741 1748
27. J.T. Keating, A. Cviko, and S. Riethdorf Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia Am J Surg Pathol 25 2001 884 891
28. C.S. Kong, B.L. Balzer, and M.L. Troxell p16INK4A immunohistochemistry is superior to HPV in situ hybridization for the detection of high-risk HPV in atypical squamous metaplasia Am J Surg Pathol 31 2007 33 43
29. A.M. de Roda Husman, J.M. Walboomers, and A.J. van den Brule The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR J Gen Virol 76 Pt 4 1995 1057 1062
30. M. Schmitz, C. Scheungraber, and J. Herrmann Quantitative multiplex PCR assay for the detection of the seven clinically most relevant high-risk HPV types J Clin Virol 44 2009 302 307
31. S.M. Dong, S.I. Pai, and S.H. Rha Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma Cancer Epidemiol Biomarkers Prev 11 2002 3 6
32. A.T. Chan, B.B. Ma, and Y.M. Lo Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: Therapeutic monitoring with plasma Epstein-Barr virus DNA J Clin Oncol 22 2004 3053 3060
33. W. Pornthanakasem, K. Shotelersuk, and W. Termrungruanglert Human papillomavirus DNA in plasma of patients with cervical cancer BMC Cancer 1 2001 2
34. H. Kedzia, A. Gozdzicka-Jozefiak, and M. Wolna Distribution of human papillomavirus 16 in the blood of women with uterine cervix carcinoma Eur J Gynaecol Oncol 13 1992 522 526
35. Y. Agrawal, W.M. Koch, and W. Xiao Oral human papillomavirus infection before and after treatment for human papillomavirus 16-positive and human papillomavirus 16-negative head and neck squamous cell carcinoma Clin Cancer Res 14 2008 7143 7150